Page 2 - Japanese (NIKKEI) Pharmaceuticals & Biotech Stocks - Top Gainers Today

UPDATED Apr 20, 2024

Explore the Japanese (NIKKEI) Top Gainers Today. These Pharmaceuticals & Biotech Stocks have seen the largest rise in Market Cap from the previous trading day.

87 companies
CompanyLast Price1D Return1Y ReturnMarket CapAnalysts TargetValuationGrowthDiv Yield

4889

Renascience
JP¥334.00-2.3%-30.3%JP¥4.2bn/aPS22.3xn/an/a

4890

Tsubota Laboratory
JP¥345.00-1.1%-57.6%JP¥8.8bn/aPS35.9xn/an/a

4892

Cyfuse Biomedical K.K
JP¥684.00-2.0%-43.5%JP¥5.4bn/aPS88.5xn/an/a

4594

BrightPath Biotherapeutics
JP¥56.00-3.4%-65.0%JP¥3.8bn/an/an/an/a

4570

Immuno-Biological Laboratories
JP¥436.00-3.5%4.6%JP¥4.1bn/aPS5.2xn/a0%

4583

Chiome Bioscience
JP¥127.00-2.3%-40.7%JP¥7.0bn/aPS10.2xn/an/a

4596

Kubota Pharmaceutical Holdings
JP¥68.00-4.2%-39.3%JP¥3.8bn/aPS98.1xn/an/a

4597

Solasia Pharma K.K
JP¥25.00-3.8%-45.7%JP¥4.3bJP¥100.00PS7xE61.9%n/a

4572

Carna Biosciences
JP¥440.00-2.2%-32.3%JP¥7.5bn/aPS4.6xn/an/a

4598

Delta-Fly Pharma
JP¥794.00-2.9%-39.6%JP¥6.5bn/aPB3.9xn/an/a

4881

FunPep
JP¥143.00-5.3%-23.5%JP¥3.7bn/aPB1.6xn/an/a

4563

AnGes
JP¥50.00-2.0%-53.3%JP¥10.1bn/aPS66.2xn/an/a

2183

Linical
JP¥390.00-2.3%-44.6%JP¥8.8bJP¥500.00PE13xE9.1%3.8%

7776

CellSeed
JP¥204.00-3.3%-61.0%JP¥6.5bn/an/an/an/a

4582

SymBio Pharmaceuticals
JP¥174.00-2.8%-59.5%JP¥7.8bn/aPS1.4xn/an/a

4586

MedRx
JP¥115.00-5.0%-23.8%JP¥4.4bn/aPS152.6xn/an/a

7777

3-D Matrix
JP¥115.00-2.5%-30.7%JP¥9.1bn/aPS2.4xn/an/a

4548

Seikagaku
JP¥740.00-0.7%-10.3%JP¥40.4bJP¥800.00PE30.8xE14.7%3.5%

4538

Fuso Pharmaceutical IndustriesLtd
JP¥2,199.00-1.5%7.5%JP¥18.6bn/an/an/a2.7%

130A

Veritas In Silico
JP¥1,620.00-2.9%n/aJP¥10.3bn/an/an/an/a

8095

Astena Holdings
JP¥479.00-1.6%9.9%JP¥19.0bn/aPE11.7xn/a3.8%

4521

Kaken Pharmaceutical
JP¥3,414.00-0.3%-8.3%JP¥129.3bJP¥3,500.00PE43.6xE-30.7%4.4%

4571

NANO MRNALtd
JP¥174.00-2.8%-21.6%JP¥12.2bn/aPS74.7xn/an/a

4579

RaQualia Pharma
JP¥591.00-3.1%-27.9%JP¥12.8bJP¥1,800.00PS6.7xn/an/a
Page 2 of 4
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.